Alaunos Therapeutics, Inc.
TCRT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,159 | -$1,051 | -$1,073 | -$742 |
| Dep. & Amort. | $0 | $0 | $0 | -$1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $68 | $81 |
| Change in WC | $14 | $135 | $233 | $70 |
| Other Non-Cash | $301 | $215 | $0 | $0 |
| Operating Cash Flow | -$844 | -$701 | -$772 | -$592 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$97 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$97 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $3,261 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $3,261 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$941 | $2,560 | -$772 | -$592 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,879 | $319 | $1,091 | $1,683 |
| End Cash | $1,938 | $2,879 | $319 | $1,091 |
| Free Cash Flow | -$941 | -$701 | -$772 | -$592 |